Edition:
United Kingdom

Novocure Ltd (NVCR.OQ)

NVCR.OQ on NASDAQ Stock Exchange Global Select Market

36.34USD
4:34pm GMT
Change (% chg)

$0.90 (+2.54%)
Prev Close
$35.44
Open
$36.07
Day's High
$36.84
Day's Low
$35.73
Volume
94,345
Avg. Vol
244,975
52-wk High
$53.70
52-wk Low
$19.23

Chart for

About

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM)... (more)

Overall

Beta: --
Market Cap(Mil.): $1,606.50
Shares Outstanding(Mil.): 89.00
Dividend: --
Yield (%): --

Financials

  NVCR.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.09 -- --
ROI: -43.41 9.01 14.96
ROE: -62.47 10.15 16.52

Earnings vs. Estimates